Boston Scientific Corp (BSX)

$48.99-0.24%
Spriggl Score: Good— see the number + sub-scores with a free Spriggl account
Last 30 trading days
Spriggl AI Verdict

FARAPULSE leads cardiac ablation; 2026 guidance cut and Penumbra debt cloud near-term despite exceptional long-run growth.

Sign up free to read the full investment thesis, bull case, bear case and what to watch.

About Boston Scientific Corp

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal

Sector:
Healthcare
Industry:
Medical Devices
Market Cap:
$79.6B

Recent dividends

No recent dividends recorded.

Get the full Spriggl analysis — free

Sign up for a free Spriggl account to unlock the full Spriggl Score breakdown, screener, watchlist, and AI investment analysis on Boston Scientific Corp and 1,600+ UK and US stocks.

Start free